An epithelial-mesenchymal transition (EMT) gene signature to predict resistance to EGFR inhibition and AXL identification as a therapeutic target in head and neck squamous cell carcinoma.
Robert Cardnell
No relevant relationships to disclose
Lixia Diao
No relevant relationships to disclose
Jing Wang
No relevant relationships to disclose
David Bearss
No relevant relationships to disclose
Steven Warner
No relevant relationships to disclose
You Hong Fan
No relevant relationships to disclose
Uma Giri
No relevant relationships to disclose
Michael D. Story
No relevant relationships to disclose
John N. Weinstein
No relevant relationships to disclose
Kevin R. Coombes
No relevant relationships to disclose
Michelle D. Williams
No relevant relationships to disclose
The Cancer Genome Atlas Reseach Network
No relevant relationships to disclose
Ignacio Ivan Wistuba
No relevant relationships to disclose
Gordon B. Mills
No relevant relationships to disclose
Jeffrey Myers
No relevant relationships to disclose
William Nassib William
Research Funding - Astellas Pharma; Lilly
K. Kian Ang
No relevant relationships to disclose
John Heymach
No relevant relationships to disclose
Lauren Averett Byers
No relevant relationships to disclose